METHADONE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methadone Hydrochloride, and what generic alternatives are available?
Methadone Hydrochloride is a drug marketed by Hikma, Lannett Co Inc, Specgx Llc, Vistapharm, Long Grove Pharms, Mylan Institutional, Mallinckrodt Inc, Ascent Pharms Inc, Aurolife Pharma Llc, Epic Pharma Llc, Nostrum Labs Inc, Roxane, Sun Pharm Industries, and Thepharmanetwork Llc. and is included in twenty-eight NDAs.
The generic ingredient in METHADONE HYDROCHLORIDE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methadone Hydrochloride
A generic version of METHADONE HYDROCHLORIDE was approved as methadone hydrochloride by ROXANE on March 8th, 1983.
Summary for METHADONE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 14 |
NDAs: | 28 |
Finished Product Suppliers / Packagers: | 18 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 369 |
Patent Applications: | 3,259 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for METHADONE HYDROCHLORIDE |
What excipients (inactive ingredients) are in METHADONE HYDROCHLORIDE? | METHADONE HYDROCHLORIDE excipients list |
DailyMed Link: | METHADONE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for METHADONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Netherlands Cancer Institute | Phase 2 |
Het Zwarte Gat | Phase 2 |
Radboud University Medical Center | Phase 2 |
Pharmacology for METHADONE HYDROCHLORIDE
Drug Class | Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |